Keycare Drugs Profile
Key Indicators
- Authorised Capital ₹ 9.99 Cr
as on 30-12-2024
- Paid Up Capital ₹ 9.99 Cr
as on 30-12-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.50 Cr
as on 30-12-2024
- Revenue %
(FY 2021)
- Profit -171.37%
(FY 2021)
- Ebitda 23.27%
(FY 2021)
- Net Worth 1225.23%
(FY 2021)
- Total Assets 26434.91%
(FY 2021)
About Keycare Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.99 Cr and a paid-up capital of Rs 9.99 Cr.
The company currently has active open charges totaling ₹7.50 Cr.
Archana Thanniru, Bhavanam Reddy, Prakash Janagama, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299TG2019PTC136467
- Company No.
136467
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Keycare Drugs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archana Thanniru  | Director | 30-Oct-2019 | Current |
Bhavanam Reddy  | Director | 03-Oct-2020 | Current |
| Prakash Janagama | Director | 03-Oct-2020 | Current |
| Akkineni Rao | Director | 03-Oct-2020 | Current |
Financial Performance of Keycare Drugs.
Keycare Drugs Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 171.37% decrease in profit. The company's net worth Soared by an impressive increase of 1225.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Keycare Drugs?
In 2021, Keycare Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
United Bank Of India Creation Date: 01 Aug 2023 | ₹3.50 Cr | Open |
Others Creation Date: 15 Apr 2023 | ₹4.00 Cr | Open |
How Many Employees Work at Keycare Drugs?
Unlock and access historical data on people associated with Keycare Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Keycare Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Keycare Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
